Concepts (206)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 14 | 2024 | 2482 | 3.340 |
Why?
|
| Breast | 3 | 2021 | 214 | 1.720 |
Why?
|
| Papilloma, Intraductal | 2 | 2024 | 5 | 1.550 |
Why?
|
| Carcinoma, Lobular | 2 | 2020 | 24 | 1.380 |
Why?
|
| Biopsy, Large-Core Needle | 4 | 2024 | 29 | 1.340 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 2020 | 82 | 1.330 |
Why?
|
| Lymph Nodes | 2 | 2022 | 374 | 1.250 |
Why?
|
| Carcinoma | 4 | 2019 | 278 | 1.140 |
Why?
|
| Biomarkers, Tumor | 7 | 2021 | 1430 | 1.090 |
Why?
|
| Sentinel Lymph Node Biopsy | 2 | 2021 | 53 | 0.950 |
Why?
|
| Pregnancy Complications, Neoplastic | 2 | 2021 | 61 | 0.880 |
Why?
|
| Sentinel Lymph Node | 1 | 2021 | 7 | 0.780 |
Why?
|
| Cervix Uteri | 1 | 2022 | 70 | 0.770 |
Why?
|
| Pathologists | 1 | 2021 | 29 | 0.770 |
Why?
|
| Carcinoma, Acinar Cell | 1 | 2021 | 4 | 0.750 |
Why?
|
| Triple Negative Breast Neoplasms | 2 | 2021 | 225 | 0.740 |
Why?
|
| Placenta | 2 | 2022 | 493 | 0.730 |
Why?
|
| Breast Carcinoma In Situ | 1 | 2020 | 1 | 0.720 |
Why?
|
| CDX2 Transcription Factor | 1 | 2020 | 9 | 0.720 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2020 | 18 | 0.710 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2020 | 62 | 0.680 |
Why?
|
| Carcinoma in Situ | 1 | 2020 | 68 | 0.680 |
Why?
|
| Axilla | 1 | 2019 | 38 | 0.660 |
Why?
|
| Nevus | 1 | 2019 | 36 | 0.650 |
Why?
|
| Neoplasms, Muscle Tissue | 1 | 2019 | 10 | 0.640 |
Why?
|
| Skin Neoplasms | 2 | 2023 | 804 | 0.640 |
Why?
|
| Immunohistochemistry | 5 | 2023 | 1684 | 0.640 |
Why?
|
| Tracheal Neoplasms | 1 | 2018 | 21 | 0.620 |
Why?
|
| Gastrointestinal Tract | 1 | 2020 | 208 | 0.610 |
Why?
|
| Oncogene Proteins | 1 | 2018 | 137 | 0.590 |
Why?
|
| Fibrocystic Breast Disease | 1 | 2016 | 5 | 0.550 |
Why?
|
| Apocrine Glands | 1 | 2016 | 4 | 0.550 |
Why?
|
| Melanoma | 1 | 2023 | 836 | 0.550 |
Why?
|
| Lung Neoplasms | 2 | 2018 | 1581 | 0.550 |
Why?
|
| Chromosomes, Human, Pair 14 | 2 | 2013 | 100 | 0.520 |
Why?
|
| Female | 26 | 2024 | 65310 | 0.490 |
Why?
|
| Liver | 1 | 2022 | 1727 | 0.490 |
Why?
|
| Fibroma | 1 | 2014 | 30 | 0.460 |
Why?
|
| Ossification, Heterotopic | 1 | 2014 | 41 | 0.460 |
Why?
|
| Paired Box Transcription Factors | 1 | 2014 | 75 | 0.460 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2014 | 53 | 0.460 |
Why?
|
| CD5 Antigens | 1 | 2014 | 37 | 0.460 |
Why?
|
| Thymus Neoplasms | 1 | 2014 | 29 | 0.460 |
Why?
|
| Mammary Glands, Human | 1 | 2014 | 79 | 0.450 |
Why?
|
| Precancerous Conditions | 1 | 2016 | 288 | 0.440 |
Why?
|
| Hemangioendothelioma, Epithelioid | 1 | 2013 | 8 | 0.430 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2013 | 78 | 0.430 |
Why?
|
| Loss of Heterozygosity | 1 | 2013 | 124 | 0.420 |
Why?
|
| Microsatellite Repeats | 1 | 2013 | 219 | 0.400 |
Why?
|
| Humans | 32 | 2024 | 122998 | 0.400 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 1267 | 0.400 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2013 | 184 | 0.390 |
Why?
|
| Meningioma | 1 | 2013 | 103 | 0.390 |
Why?
|
| Diagnosis, Differential | 5 | 2020 | 1870 | 0.380 |
Why?
|
| Middle Aged | 13 | 2024 | 25931 | 0.380 |
Why?
|
| Meningeal Neoplasms | 1 | 2013 | 167 | 0.370 |
Why?
|
| Translocation, Genetic | 1 | 2013 | 351 | 0.370 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2011 | 68 | 0.350 |
Why?
|
| Transcription Factors | 1 | 2020 | 2577 | 0.350 |
Why?
|
| Anemia | 1 | 2013 | 339 | 0.320 |
Why?
|
| Biopsy | 3 | 2020 | 1239 | 0.290 |
Why?
|
| Aged | 7 | 2024 | 19035 | 0.260 |
Why?
|
| Neoplasm Proteins | 2 | 2021 | 670 | 0.250 |
Why?
|
| India | 5 | 2013 | 217 | 0.250 |
Why?
|
| Mastectomy | 2 | 2021 | 63 | 0.230 |
Why?
|
| Adult | 7 | 2024 | 28980 | 0.220 |
Why?
|
| Leiomyoma | 1 | 2024 | 90 | 0.210 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2024 | 342 | 0.210 |
Why?
|
| Uterine Neoplasms | 1 | 2024 | 118 | 0.210 |
Why?
|
| Proteogenomics | 1 | 2023 | 69 | 0.210 |
Why?
|
| Pathology Department, Hospital | 1 | 2021 | 1 | 0.200 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2024 | 491 | 0.200 |
Why?
|
| Body Composition | 1 | 2024 | 513 | 0.200 |
Why?
|
| Brain Neoplasms | 1 | 2011 | 1212 | 0.190 |
Why?
|
| Pelvis | 1 | 2022 | 68 | 0.190 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2024 | 237 | 0.190 |
Why?
|
| Anoctamin-1 | 1 | 2021 | 3 | 0.190 |
Why?
|
| Proto-Oncogene Proteins c-ret | 1 | 2021 | 29 | 0.190 |
Why?
|
| GATA3 Transcription Factor | 1 | 2021 | 39 | 0.190 |
Why?
|
| Canada | 1 | 2021 | 294 | 0.180 |
Why?
|
| Embryonic Development | 1 | 2022 | 208 | 0.180 |
Why?
|
| Crystal Arthropathies | 1 | 2020 | 1 | 0.180 |
Why?
|
| Synovial Membrane | 1 | 2020 | 27 | 0.180 |
Why?
|
| Lymphatic Metastasis | 1 | 2021 | 398 | 0.180 |
Why?
|
| Pregnancy | 3 | 2022 | 7115 | 0.180 |
Why?
|
| Muscle Neoplasms | 1 | 2020 | 21 | 0.180 |
Why?
|
| Academic Medical Centers | 1 | 2021 | 298 | 0.170 |
Why?
|
| Neoplasm Micrometastasis | 1 | 2019 | 12 | 0.170 |
Why?
|
| Kidney Neoplasms | 1 | 2024 | 426 | 0.170 |
Why?
|
| Ultrasonography, Mammary | 1 | 2019 | 28 | 0.160 |
Why?
|
| Neoadjuvant Therapy | 1 | 2021 | 321 | 0.160 |
Why?
|
| DNA Mutational Analysis | 1 | 2021 | 793 | 0.160 |
Why?
|
| Mammography | 1 | 2019 | 113 | 0.150 |
Why?
|
| Exophthalmos | 1 | 2018 | 37 | 0.150 |
Why?
|
| Neoplasm Metastasis | 1 | 2020 | 649 | 0.150 |
Why?
|
| Ultrasonography, Interventional | 1 | 2019 | 196 | 0.150 |
Why?
|
| Orbital Neoplasms | 1 | 2018 | 65 | 0.140 |
Why?
|
| Infant, Newborn | 4 | 2022 | 8070 | 0.140 |
Why?
|
| Orbit | 1 | 2018 | 102 | 0.140 |
Why?
|
| Gout | 1 | 2020 | 145 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2024 | 2041 | 0.140 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2021 | 714 | 0.140 |
Why?
|
| Bacteria | 1 | 2020 | 483 | 0.140 |
Why?
|
| Vision Disorders | 1 | 2018 | 210 | 0.130 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 864 | 0.130 |
Why?
|
| Bone Neoplasms | 1 | 2020 | 426 | 0.130 |
Why?
|
| Diagnostic Errors | 1 | 2019 | 321 | 0.130 |
Why?
|
| Cell Movement | 1 | 2019 | 831 | 0.130 |
Why?
|
| Metaplasia | 1 | 2016 | 216 | 0.130 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 6359 | 0.130 |
Why?
|
| Microbiota | 1 | 2020 | 392 | 0.120 |
Why?
|
| Gastroenteritis | 2 | 2008 | 337 | 0.120 |
Why?
|
| Membrane Transport Proteins | 1 | 2016 | 177 | 0.120 |
Why?
|
| Rotavirus Infections | 2 | 2008 | 348 | 0.120 |
Why?
|
| Rhabdomyosarcoma | 1 | 2018 | 199 | 0.120 |
Why?
|
| Mucinoses | 1 | 2014 | 2 | 0.120 |
Why?
|
| Mitochondrial Turnover | 1 | 2014 | 3 | 0.120 |
Why?
|
| Fibroadenoma | 1 | 2014 | 9 | 0.120 |
Why?
|
| Follow-Up Studies | 1 | 2024 | 5031 | 0.120 |
Why?
|
| Enzyme Activators | 1 | 2014 | 11 | 0.120 |
Why?
|
| Heterocyclic Compounds, 4 or More Rings | 1 | 2014 | 25 | 0.120 |
Why?
|
| Young Adult | 2 | 2018 | 8840 | 0.120 |
Why?
|
| PAX8 Transcription Factor | 1 | 2014 | 15 | 0.120 |
Why?
|
| Glycoproteins | 1 | 2016 | 369 | 0.110 |
Why?
|
| Sirtuin 1 | 1 | 2014 | 47 | 0.110 |
Why?
|
| Male | 9 | 2020 | 59901 | 0.110 |
Why?
|
| Ultrasonography | 1 | 2019 | 945 | 0.110 |
Why?
|
| Reperfusion Injury | 1 | 2014 | 102 | 0.110 |
Why?
|
| Cross Reactions | 1 | 2014 | 192 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2013 | 66 | 0.110 |
Why?
|
| Surveys and Questionnaires | 2 | 2021 | 3657 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2013 | 102 | 0.100 |
Why?
|
| Signal Transduction | 1 | 2024 | 4507 | 0.100 |
Why?
|
| Adolescent | 3 | 2018 | 19030 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2021 | 2595 | 0.100 |
Why?
|
| Bone Marrow | 1 | 2013 | 322 | 0.090 |
Why?
|
| Carrier Proteins | 1 | 2016 | 1021 | 0.090 |
Why?
|
| Nerve Sheath Neoplasms | 1 | 2011 | 21 | 0.090 |
Why?
|
| Craniopharyngioma | 1 | 2011 | 33 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2013 | 371 | 0.090 |
Why?
|
| Hospitals | 2 | 2011 | 397 | 0.090 |
Why?
|
| Astrocytoma | 1 | 2011 | 102 | 0.090 |
Why?
|
| Kidney Diseases | 1 | 2014 | 478 | 0.090 |
Why?
|
| Age Distribution | 1 | 2011 | 410 | 0.090 |
Why?
|
| Ependymoma | 1 | 2011 | 133 | 0.080 |
Why?
|
| United States | 2 | 2021 | 10595 | 0.080 |
Why?
|
| Diarrhea | 2 | 2008 | 315 | 0.080 |
Why?
|
| Nurseries, Hospital | 1 | 2008 | 6 | 0.080 |
Why?
|
| Diarrhea, Infantile | 1 | 2008 | 36 | 0.080 |
Why?
|
| Cryptosporidiosis | 1 | 2007 | 41 | 0.070 |
Why?
|
| Medulloblastoma | 1 | 2011 | 338 | 0.070 |
Why?
|
| Kidney | 1 | 2014 | 1337 | 0.070 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2007 | 138 | 0.070 |
Why?
|
| Cell Differentiation | 1 | 2014 | 1915 | 0.070 |
Why?
|
| Cost of Illness | 1 | 2008 | 242 | 0.070 |
Why?
|
| Infant, Premature, Diseases | 1 | 2008 | 238 | 0.070 |
Why?
|
| Health Care Costs | 1 | 2008 | 365 | 0.060 |
Why?
|
| Rotavirus | 1 | 2008 | 492 | 0.060 |
Why?
|
| Prognosis | 1 | 2013 | 4490 | 0.060 |
Why?
|
| NFI Transcription Factors | 1 | 2023 | 50 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2023 | 83 | 0.050 |
Why?
|
| Neurofibromin 1 | 1 | 2023 | 42 | 0.050 |
Why?
|
| Nephrectomy | 1 | 2024 | 172 | 0.050 |
Why?
|
| Hysterectomy | 1 | 2024 | 185 | 0.050 |
Why?
|
| Child | 2 | 2013 | 24144 | 0.050 |
Why?
|
| Adipose Tissue | 1 | 2024 | 465 | 0.050 |
Why?
|
| Tumor Microenvironment | 1 | 2024 | 538 | 0.050 |
Why?
|
| Symptom Assessment | 1 | 2020 | 98 | 0.040 |
Why?
|
| Hospitalization | 1 | 2008 | 1732 | 0.040 |
Why?
|
| Receptors, Estrogen | 1 | 2023 | 789 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2021 | 757 | 0.040 |
Why?
|
| Incidental Findings | 1 | 2020 | 124 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2023 | 519 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2021 | 15931 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2014 | 12087 | 0.040 |
Why?
|
| Infant | 2 | 2011 | 12286 | 0.040 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2019 | 168 | 0.040 |
Why?
|
| Fundus Oculi | 1 | 2018 | 63 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2011 | 13819 | 0.040 |
Why?
|
| Receptor, ErbB-2 | 1 | 2021 | 495 | 0.040 |
Why?
|
| Fluorescein Angiography | 1 | 2018 | 138 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2023 | 2820 | 0.030 |
Why?
|
| Cesarean Section | 1 | 2019 | 381 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2020 | 1386 | 0.030 |
Why?
|
| Endoscopy | 1 | 2018 | 283 | 0.030 |
Why?
|
| Retina | 1 | 2018 | 457 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2014 | 619 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 233 | 0.030 |
Why?
|
| Tomography, Optical Coherence | 1 | 2018 | 514 | 0.030 |
Why?
|
| Disease Progression | 1 | 2018 | 2027 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 481 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2014 | 1211 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2014 | 766 | 0.020 |
Why?
|
| Cell Line | 1 | 2014 | 2779 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2014 | 796 | 0.020 |
Why?
|
| Cryptosporidium | 1 | 2007 | 32 | 0.020 |
Why?
|
| Rats | 1 | 2014 | 3629 | 0.020 |
Why?
|
| Water | 1 | 2007 | 182 | 0.020 |
Why?
|
| Urban Population | 1 | 2007 | 219 | 0.020 |
Why?
|
| Rural Population | 1 | 2007 | 249 | 0.020 |
Why?
|
| Feces | 1 | 2008 | 710 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 4263 | 0.010 |
Why?
|
| Infant, Premature | 1 | 2008 | 798 | 0.010 |
Why?
|
| Genotype | 1 | 2008 | 2546 | 0.010 |
Why?
|
| Animals | 2 | 2014 | 33693 | 0.010 |
Why?
|
| Risk Factors | 1 | 2007 | 9974 | 0.010 |
Why?
|